Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,657 | -7,642 | -15,191 | 2,431 | -18,807 |
| Depreciation Amortization | 144 | 172 | 158 | 144 | 126 |
| Accounts receivable | 88 | 117 | 140 | -121 | -11 |
| Accounts payable and accrued liabilities | 1,840 | N/A | -347 | -1,542 | 508 |
| Other Working Capital | 1,506 | -55 | -555 | -2,863 | 764 |
| Other Operating Activity | 25 | 587 | 1,933 | -12,280 | 2,966 |
| Operating Cash Flow | $-10,055 | $-6,822 | $-13,862 | $-14,231 | $-14,454 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -548 | N/A | 22,684 | -32 | -194 |
| Purchase Of Investment | -6,130 | -6,002 | -18,012 | -18,986 | -17,997 |
| Sale Of Investment | 12,117 | 3,000 | N/A | 24,000 | 13,000 |
| Investing Cash Flow | $5,439 | $-3,002 | $4,672 | $4,982 | $-5,191 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 500 | 4,750 |
| Debt Issued | 318 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 33,064 | 9,178 | 6,854 | 11,080 | 13,879 |
| Financing Cash Flow | $33,382 | $9,178 | $6,854 | $11,580 | $18,629 |
| Beginning Cash Position | 3,899 | 4,545 | 6,882 | 4,552 | 5,568 |
| End Cash Position | 32,666 | 3,899 | 4,545 | 6,882 | 4,552 |
| Net Cash Flow | $28,767 | $-646 | $-2,337 | $2,331 | $-1,017 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,055 | -6,822 | -13,862 | -14,231 | -14,454 |
| Capital Expenditure | -548 | N/A | -317 | -32 | -194 |
| Free Cash Flow | -10,602 | -6,822 | -14,179 | -14,263 | -14,648 |